Skip to main content
XERS logo

Xeris Biopharma Holdings, Inc.

XERSNASDAQHealthcareDrug Manufacturers - Specialty & Generic

$10.45Today:- (-)1Y +18.95%

As of Oct 27, 2026 close

Market cap
$1.81B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$5.25$11.42
Volume (live)
-
Avg. volume (3M)
3.08M

Xeris Biopharma Holdings, Inc. (XERS) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Xeris Biopharma Holdings, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(8 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$13.00
+24.40% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest XERS Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Jenna Davidner
Barclays
BuyMaintains
$12.00 → $14.00
Chase Knickerbocker
Craig-Hallum
BuyMaintains
$12.00
Brandon Folkes
HC Wainwright
BuyMaintains
$10.00
David Amsellem
Piper Sandler
HoldReiterates
$8.00
Roanna Ruiz
Leerink Partners
BuyReiterates
$12.00 → $16.00
Unknown Analyst
Oppenheimer
BuyReiterates
$18.00
Edmund Ingham
Forbes
BuyInitiates Coverage
-
Unknown Analyst
Oppenheimer
BuyReiterates
$18.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 6, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for XERS?

The analyst consensus rating for XERS is Buy, based on the latest ratings from 7 analysts over the last 90 days.

What is the average price target for XERS?

The average 12-month price target for XERS is $13.00, representing an upside of 24.4% from the Oct 27, 2026 close of $10.45.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.